Skip to content
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Gynecology · Atypical Polypoid Adenomyoma

Atypical Polypoid Adenomyoma (APA): A Patient Guide

At a Glance

Atypical polypoid adenomyoma is a rare growth in the uterine lining that is not cancer itself but can be linked with precancer or cancer. Hysteroscopy and expert tissue review guide treatment, which may preserve fertility or involve hysterectomy and long-term monitoring.

Atypical Polypoid Adenomyoma (APA) is a rare, complex growth found in the lining of the uterus. While it is not cancer itself, it is classified as a premalignant-associated lesion. This means it has an important association with coexisting or subsequently detected endometrial cancer or precancer (EIN). Under a microscope, APA is “biphasic,” meaning it consists of two distinct parts: unusual, active glands and a surrounding shell of tough, muscle-like tissue. This unique structure requires a specialized approach to both diagnosis and long-term care [1][2].

Because APA often mimics the appearance of more aggressive conditions, the path to a correct diagnosis is crucial. Standard imaging like ultrasound can identify a mass, but it cannot confirm it is APA. Furthermore, a blind biopsy in the office can sometimes miss the lesion or provide an incomplete tissue sample that is difficult for a pathologist to interpret. For this reason, a guided procedure using a small camera—called a hysteroscopy—is the preferred way to see the growth clearly and remove an adequate specimen for an expert pathology review [3][4].

Treatment for APA is highly personalized and centers on your future goals for childbearing. For those who wish to preserve their fertility, experienced surgeons can perform a precise hysteroscopic resection to remove the growth while leaving the uterus intact. However, because APA has a meaningful rate of recurrence or persistence, other patients may choose a hysterectomy. A hysterectomy is a definitive surgical option that removes the uterine site where the disease occurs, though it comes with permanent loss of fertility and surgical considerations. There is no one-size-fits-all answer, and the decision involves balancing your desire for a future pregnancy against the risks of recurrence and the burden of ongoing surveillance [2][5].

Choosing the fertility-sparing path means entering a phase of active, long-term surveillance. This involves regular check-ups and repeat tissue biopsies to ensure the uterine lining remains healthy. While this journey requires patience and a commitment to frequent monitoring, the outlook for many is hopeful. Research shows that for patients who successfully clear the lesion, achieving a healthy pregnancy is a realistic goal [3][6].

Please note: This resource is intended to provide helpful information and context about APA, but it does not replace individualized medical advice from your gynecologist, gynecologic pathologist, gynecologic oncologist, or fertility specialist.

Common questions in this guide

What is atypical polypoid adenomyoma, and is it cancer?
Atypical polypoid adenomyoma (APA) is a rare growth in the uterine lining made of abnormal glands and muscle-like tissue. It is not cancer itself, but it is associated with precancer or endometrial cancer that may be present at the same time or found later, so careful evaluation is important.
How is atypical polypoid adenomyoma diagnosed?
An ultrasound may show a uterine mass but cannot confirm APA. A hysteroscopy uses a small camera to view the growth directly and remove enough tissue for an expert pathologist to examine; an office biopsy done without visual guidance can miss the lesion or provide an incomplete sample.
Can APA be treated while preserving fertility?
Often, yes. For people who want a future pregnancy, an experienced surgeon may remove APA through hysteroscopic resection while leaving the uterus in place. Because the lesion can persist or return, fertility-sparing treatment requires regular follow-up and repeat tissue sampling.
When is hysterectomy considered for APA?
Hysterectomy removes the uterus and is a definitive option for APA, but it permanently ends the ability to carry a pregnancy. It may be considered when fertility preservation is not a goal or when a person prefers to avoid the recurrence risk and prolonged monitoring associated with fertility-sparing care. The choice should be individualized with a qualified care team.
What follow-up is needed after fertility-sparing APA treatment?
Fertility-sparing care includes long-term surveillance with regular check-ups and repeat biopsies or tissue sampling to confirm that the uterine lining remains healthy. Your gynecologist should set the monitoring plan based on your pathology results, treatment, and fertility plans.
Can I get pregnant after APA treatment?
For many patients, achieving a healthy pregnancy after the lesion is successfully cleared is a realistic goal. A fertility specialist can help coordinate pregnancy planning while the gynecology team continues appropriate surveillance.
Should I see a gynecologic oncologist for APA?
Because APA can occur with precancer or endometrial cancer and can be difficult to distinguish from more aggressive conditions, expert review of the tissue is important. Ask whether a gynecologic oncologist and gynecologic pathologist should be involved in confirming the diagnosis and planning treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my complete pathology report, do you consider my risk for concurrent EIN or cancer to be fully evaluated?
  2. 2.Are you comfortable performing a complete fertility-sparing hysteroscopic resection, or should I see a gynecologic oncology specialist?
  3. 3.How will we coordinate my care with a fertility specialist if I decide to pursue pregnancy?
  4. 4.How often will we need to perform follow-up biopsies to monitor for recurrence?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.

    Travaglino A, Raffone A, Saccone G, et al.

    Applied immunohistochemistry & molecular morphology : AIMM 2020; (28(8)):646-653 doi:10.1097/PAI.0000000000000780.

    PMID: 31855579
  2. 2

    Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review.

    Raffone A, Travaglino A, Saccone G, et al.

    Acta obstetricia et gynecologica Scandinavica 2019; (98(7)):842-855 doi:10.1111/aogs.13553.

    PMID: 30714089
  3. 3

    Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis.

    Biasioli A, Londero AP, Orsaria M, et al.

    Medicine 2020; (99(26)):e20491 doi:10.1097/MD.0000000000020491.

    PMID: 32590732
  4. 4

    MRI and Transvaginal Ultrasound Findings of Atypical Polypoid Adenomyoma: A Case Report.

    Tan Y, Hu X, Song X, Zhang WJ

    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2022; (37(1)):82-86 doi:10.24920/003911.

    PMID: 35256047
  5. 5

    Clinical presentation and management of atypical polypoid adenomyomas: Systematic review of the literature.

    Mikos T, Tsolakidis D, Grimbizis GF

    European journal of obstetrics, gynecology, and reproductive biology 2019; (236()):14-21 doi:10.1016/j.ejogrb.2019.02.027.

    PMID: 30875539
  6. 6

    Hysteroscopic Transcervical Resection for Atypical Polypoid Adenomyoma of the Uterus: A Valid, Fertility-Preserving Option.

    Chiyoda T, Lin BL, Saotome K, et al.

    Journal of minimally invasive gynecology 2018; (25(1)):163-169.e1 doi:10.1016/j.jmig.2017.08.659.

    PMID: 29038039

This page about atypical polypoid adenomyoma is for informational purposes only and does not constitute medical advice. Your gynecologist and appropriate specialists can help interpret your results and discuss treatment, fertility, and surveillance choices.

Get notified when new evidence is published on uterine corpus atypical polypoid adenomyoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.